Subash Rajavel3 min readThe Future of BiosimilarsIn the United States, Biologics account for 40% of all pharmaceutical spending, however fewer than 2% of Americans use them. What makes...
Subash Rajavel4 min readDCT and the deluge of dataThe new fashionable kid in the world of clinical trials is obviously DCT aka the Decentralized Clinical Trials. Like other dormant trends...
Subash Rajavel4 min readThe future of patient engagementI called one of my specialist Doctor’s offices to send over my clinical data to my primary physician. After multiple failed attempts to...